Hsinchu, Taiwan

Mei-Lan Ko


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2021

Loading Chart...
2 patents (USPTO):

Title: Innovations by Mei-Lan Ko in Alzheimer's Disease Treatment

Introduction

Mei-Lan Ko is an accomplished inventor based in Hsinchu, Taiwan. She has made significant contributions to the field of Alzheimer's disease research through her innovative patents. With a total of two patents, her work focuses on novel techniques for diagnosis and treatment.

Latest Patents

One of Mei-Lan Ko's latest patents is an electrochemical dephosphorylation technique for treating Alzheimer's disease. This invention involves a gold electrode that operates at a negative potential of -0.2 V to -0.6 V on its surface. This technique aims to provide a new method for addressing the challenges posed by Alzheimer's disease.

Another notable patent is for color-changing eye drops designed for early screening of Alzheimer's disease. This invention includes a formulation containing 1 pg/ml to 10 ng/ml of Aβ aptamer-gold nanoparticles (AuNPs) mixed with a pharmaceutically acceptable carrier. The eye drops can be used with a tear sample from a test subject to analyze color changes, which helps determine the concentration of Aβ present in the sample.

Career Highlights

Mei-Lan Ko is affiliated with National Yang Ming Chiao Tung University, where she continues her research and development efforts. Her work is recognized for its potential impact on early diagnosis and treatment of Alzheimer's disease.

Collaborations

Mei-Lan Ko collaborates with esteemed colleagues, including Jung-Chih Chen and I-Chiu Li, who contribute to her research initiatives. Their combined expertise enhances the quality and scope of their projects.

Conclusion

Mei-Lan Ko's innovative patents represent significant advancements in the fight against Alzheimer's disease. Her contributions are paving the way for new diagnostic and therapeutic approaches that could improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…